Publications by authors named "J Haarbo"
Eur J Heart Fail
August 2024
Article Synopsis
- This study compares the prognostic value of different body measurement indices, like BMI and waist-to-height ratio, in predicting mortality in patients with non-ischaemic heart failure with reduced ejection fraction (HFrEF).
- It finds that higher BMI is linked to increased risks of all-cause and cardiovascular death, particularly in patients with a BMI of 35 or more.
- The research suggests that greater waist-to-height ratios also indicate higher mortality risk, highlighting the importance of fat location and distribution beyond just body weight.
J Card Fail
November 2024
Article Synopsis
- The Heart Failure Collaboratory (HFC) score evaluates pharmacotherapy for heart failure patients, and this study analyzed its impact in 1116 Danish patients with nonischemic heart failure with reduced ejection fraction (HFrEF).
- A lower modified HFC (mHFC) score was linked to increased all-cause mortality, while an mHFC score of 3-4 had better outcomes compared to scores of 1-2.
- Despite these findings, implanting cardioverter-defibrillators (ICDs) did not improve overall or cardiovascular survival rates in these patients, although it did reduce sudden cardiovascular deaths.
Eur J Heart Fail
June 2024
Article Synopsis
- Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for patients with heart failure and left ventricular ejection fraction ≤35%, but the benefits of ICDs in patients with NYHA class III remain uncertain.
- The DANISH trial studied 1116 patients and found that those in NYHA class III/IV had higher long-term all-cause and cardiovascular mortality rates compared to those in NYHA class II.
- Despite these findings, ICD implantation did not significantly reduce all-cause or cardiovascular mortality rates in either NYHA class, indicating a limited benefit of ICD therapy for this patient population.
J Am Heart Assoc
February 2024
Article Synopsis
- A study examined the long-term impacts of implantable cardioverter-defibrillators (ICDs) on patients with heart failure and chronic kidney disease (CKD), comparing ICD outcomes to usual care.*
-
- The study included 1116 patients, with findings showing that ICD implantation did not significantly lower overall mortality or cardiovascular death rates, regardless of CKD status.*
-
- However, ICDs were effective in reducing sudden cardiovascular deaths in both patients with and without CKD over a median follow-up of 9.5 years.*
